このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Agenus 将来の成長
Future 基準チェック /16
Agenusは、10.3%と19.3%でそれぞれ年率10.3%で利益と収益が成長すると予測される一方、EPSはgrowで23.5%年率。
主要情報
10.3%
収益成長率
23.5%
EPS成長率
Biotechs 収益成長 | 24.5% |
収益成長率 | 19.3% |
将来の株主資本利益率 | n/a |
アナリストカバレッジ | Low |
最終更新日 | 05 Jun 2024 |
今後の成長に関する最新情報
Recent updates
There's No Escaping Agenus Inc.'s (NASDAQ:AGEN) Muted Revenues Despite A 102% Share Price Rise
May 21Analysts Have Lowered Expectations For Agenus Inc. (NASDAQ:AGEN) After Its Latest Results
May 09Benign Growth For Agenus Inc. (NASDAQ:AGEN) Underpins Stock's 25% Plummet
Mar 29Agenus: 2024 May Finally Be The Year For A Major Turnaround
Jan 18Improved Revenues Required Before Agenus Inc. (NASDAQ:AGEN) Shares Find Their Feet
Dec 22News Flash: Analysts Just Made A Huge Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Forecasts
Nov 09A Look At The Fair Value Of Agenus Inc. (NASDAQ:AGEN)
Oct 04Industry Analysts Just Made A Notable Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Revenue Forecasts
May 10VBI Vaccines, Agenus to examine VBI-1901 + balstilimab combo for glioblastoma
Oct 12Agenus New Trials Set It Up For The Long Haul
Sep 27Agenus: It's Always Tomorrow
Sep 16Agenus GAAP EPS of -$0.17, revenue of $20.93M
Aug 09Agenus: Successfully Pulled Itself Away From Disaster
Jul 04Agenus: Not Quite Enough
Apr 19Auditors Have Doubts About Agenus (NASDAQ:AGEN)
Mar 06Agenus: Making Another Effort With The FDA
Jan 25Agenus Inc.'s Imminent 1181/Bal Data Release And MiNK IPO Should Lead To Enormous Valuation Gains
Aug 25Agenus Multiple Value-Adding Events Ahead
Aug 18Party Time: Brokers Just Made Major Increases To Their Agenus Inc. (NASDAQ:AGEN) Earnings Forecasts
Aug 11FDA accepts Agenus' balstilimab BLA under "priority review" status
Jun 17Agenus/Bristol-Myers Squibb Deal Makes For A Strong Buy
May 26業績と収益の成長予測
日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
---|---|---|---|---|---|
12/31/2026 | 233 | -220 | 21 | N/A | 5 |
12/31/2025 | 183 | -230 | -130 | N/A | 5 |
12/31/2024 | 206 | -185 | -58 | N/A | 5 |
3/31/2024 | 161 | -240 | -212 | -204 | N/A |
12/31/2023 | 156 | -246 | -234 | -224 | N/A |
9/30/2023 | 101 | -271 | -255 | -231 | N/A |
6/30/2023 | 99 | -263 | -234 | -198 | N/A |
3/31/2023 | 95 | -240 | -232 | -182 | N/A |
12/31/2022 | 98 | -220 | -228 | -175 | N/A |
9/30/2022 | 90 | -215 | -199 | -151 | N/A |
6/30/2022 | 320 | 18 | -42 | 13 | N/A |
3/31/2022 | 310 | -19 | -38 | 0 | N/A |
12/31/2021 | 296 | -24 | -24 | 10 | N/A |
9/30/2021 | 307 | 4 | -28 | -3 | N/A |
6/30/2021 | 69 | -226 | -170 | -166 | N/A |
3/31/2021 | 85 | -190 | -150 | -147 | N/A |
12/31/2020 | 88 | -181 | -143 | -139 | N/A |
9/30/2020 | 91 | -174 | -139 | -135 | N/A |
6/30/2020 | 97 | -168 | -135 | -131 | N/A |
3/31/2020 | 85 | -171 | -134 | -130 | N/A |
12/31/2019 | 150 | -108 | -23 | -19 | N/A |
9/30/2019 | 122 | -126 | -27 | -23 | N/A |
6/30/2019 | 115 | -113 | -24 | -19 | N/A |
3/31/2019 | 115 | -87 | -18 | -14 | N/A |
12/31/2018 | 37 | -160 | -135 | -131 | N/A |
9/30/2018 | 39 | -147 | -125 | -121 | N/A |
6/30/2018 | 29 | -151 | -127 | -123 | N/A |
3/31/2018 | 18 | -158 | -124 | -120 | N/A |
12/31/2017 | 43 | -121 | N/A | -94 | N/A |
9/30/2017 | 40 | -112 | N/A | -84 | N/A |
6/30/2017 | 41 | -116 | N/A | -82 | N/A |
3/31/2017 | 44 | -113 | N/A | -73 | N/A |
12/31/2016 | 23 | -127 | N/A | -80 | N/A |
9/30/2016 | 25 | -117 | N/A | -83 | N/A |
6/30/2016 | 27 | -89 | N/A | -78 | N/A |
3/31/2016 | 27 | -101 | N/A | -72 | N/A |
12/31/2015 | 25 | -88 | N/A | -47 | N/A |
9/30/2015 | 19 | -98 | N/A | -38 | N/A |
6/30/2015 | 14 | -93 | N/A | -28 | N/A |
3/31/2015 | 10 | -61 | N/A | -25 | N/A |
12/31/2014 | 7 | -43 | N/A | -38 | N/A |
9/30/2014 | 6 | -22 | N/A | -33 | N/A |
6/30/2014 | 5 | -22 | N/A | -30 | N/A |
3/31/2014 | 3 | -25 | N/A | -26 | N/A |
12/31/2013 | 3 | -33 | N/A | -20 | N/A |
9/30/2013 | 4 | -33 | N/A | -17 | N/A |
6/30/2013 | 4 | -32 | N/A | -16 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: AGEN今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: AGEN今後 3 年間、利益が出ない状態が続くと予測されています。
高成長収益: AGEN今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: AGENの収益 ( 19.3% ) US市場 ( 8.7% ) よりも速いペースで成長すると予測されています。
高い収益成長: AGENの収益 ( 19.3% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: AGENの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です